Preliminary analysis of the melanoma multimedia educational program for general practitioners on behalf of the Italian melanoma intergroup
https://doi.org/10.4081/dr.2024.9920
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Introduction. According to the National Oncological Plan 2023-2027 on the importance of multidisciplinary and interactive e-learning training, the Italian Melanoma Intergroup (IMI) has developed MelaMEd (Melanoma Multimedia Education), a national project for general practitioners (GPs) on the prevention and detection of cutaneous melanoma through an online platform and an online course. MelaMEd enables participants to (1) recognize skin lesions that require specialist dermatological assessment, (2) select patients at high risk of melanoma and (3) be informed of the diagnosis and treatment pathway of patients with melanoma. Methods. A free online platform and online course were developed and launched in June 2022. Before starting the course, enrolled participants fill out a pre-training questionnaire concerning the basic knowledge of the disease and the recognition and management of suspicious lesions. After the course, participants will fill out the same questionnaire again. The online course will end in December 2023. Here we present a preliminary analysis of the pre-training results (January 2023-July 2023). The data have been analyzed descriptively. Results. So far, five healthcare centers have participated in the project for a total of 1320 participants. Of these, 298 compiled the pre-training questionnaire. Forty-seven percent of them were aged <40 years. Respondents were almost divided between GPs (47%) and resident GPs (48%). Among the theoretical questions, the “ABCDE” rule and “ugly duckling” sign are well known (96% and 91% of correct answers, respectively), but a lower percentage (68%) of respondents knows the “EFG” rule for the recognition of nodular melanomas and the statement of Breslow thickness (29%). Regarding the series of clinical images of pigmented skin lesions and their management, the percentages rate of accuracy varied from 33% to 87%: melanoma (5 cases) ranges from 36% to 71%, melanocytic nevi (3 cases) from 33% to 84%, whereas the percentages rate of referral for dermatological evaluation varied from 44% to 99%. Melanoma cases referred to dermatologist ranges from 67% to 99%. Conclusions. This preliminary analysis on pre-training questionnaire mainly showed a lack of knowledge of the two major points of melanoma diagnosis (EFG) and management (Breslow thickness), as well as a low rate of participants. We will compare the proportions of correct answers to the questionnaires before and after the course once available.
Bucchi L, Mancini S, Crocetti E, et al. Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy. Int J Cancer. 2021 Feb 15;148(4):835-844. DOI: https://doi.org/10.1002/ijc.33259
Zamagni F, Bucchi L, Mancini S, et al F; AIRTUM Working Group. The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population-based investigation. Br J Dermatol. 2022 Jul;187(1):52-63. DOI: https://doi.org/10.1111/bjd.21051
Arnold M, Singh D, Laversanne M, et al. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 2022 May 1;158(5):495-503. DOI: https://doi.org/10.1001/jamadermatol.2022.0160
AM Forsea. Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities. Dermatol Pract Concept. 2020 Jul;10(3):e2020033. DOI: https://doi.org/10.5826/dpc.1003a33
Ezeonwu MC. Specialty-care access for community health clinic patients: processes and barriers. J Multidiscip Healthc. 2018;11:109- 19. DOI: https://doi.org/10.2147/JMDH.S152594
Fleischer AB Jr., Herbert CR, Feldman SR, O'Brien F. Diagnosis of skin disease by non-dermatologists. Am J Manag Care. 2000;6(10):1149- 56.
Kirsner RS, Muhkerjee S, Federman DG. Skin cancer screening in primary care: prevalence and barriers. J Am Acad Dermatol. 1999;41(4):564-6. DOI: https://doi.org/10.1016/S0190-9622(99)70297-5
Brown AE, Najmi M, Duke T, et al. Skin Cancer Education Interventions for Primary Care Providers: A Scoping Review. J Gen Intern Med. 2022 Jul;37(9):2267-2279. DOI: https://doi.org/10.1007/s11606-022-07501-9
Carli P, De Giorgi V, Crocetti E, et al. Diagnostic and referral accuracy of family doctors in melanoma screening: effect of a short formal training. Eur J Cancer Prev 2005;14:51–5. DOI: https://doi.org/10.1097/00008469-200502000-00007
Argenziano G, Puig S, Zalaudek I et al. Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol. 2006 Apr 20;24(12):1877-82. DOI: https://doi.org/10.1200/JCO.2005.05.0864
L Bucchi, S Mancini, F Zamagni et al. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations. J Eur Acad Dermatol Venereol. 2022 Sep 30. DOI: https://doi.org/10.1111/jdv.18635
Abdulrahaman MD, Faruk N, Oloyede AA, et al. Multimedia tools in the teaching and learning processes: A systematic review. Heliyon. 2020 Nov 2;6(11):e05312. DOI: https://doi.org/10.1016/j.heliyon.2020.e05312
Civitelli G, Tarsitani G, Rinaldi A, Marceca M. Medical education: an Italian contribution to the discussion on global health education. Global Health. 2020 Apr 8;16(1):30. DOI: https://doi.org/10.1186/s12992-020-00561-8
Marceglia S, Balestra G, Bottrighi A, et al. Developing the Digital Healthcare Workforce in Italy: The SIBIM Experience. Stud Health Technol Inform. 2022 Aug 31;298:46-50. DOI: https://doi.org/10.3233/SHTI220905
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
